BioSpace News Archive

Business

BIA Separations Appoints Pete Gagnon as CSO

In his new role, he will drive the company’s new product and applications development, with a focus on the purification of products for gene therapy, oncolytic vaccines, exosomes and similar, and specifically increasing the safety of these products.

January 17, 2018
·
2 min read
Ziath to Showcase New Low-Profile 2D Barcode Scanner for Liquid Handling Systems at SLAS2018

This innovative camera-based scanner has a low-profile design enabling it to be easily integrated with robotic liquid handling systems, as well as other laboratory automation solutions.

January 17, 2018
·
2 min read
Business

Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum

Baum is a highly respected biotech executive who has held leadership positions at numerous companies, from biotech startups to publicly-traded companies.

January 17, 2018
·
3 min read
Drug Development

First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology)

announces that the first patient has been dosed in a Phase 1 clinical trial in China, evaluating T101, a therapeutic vaccine based on Transgene’s immunotherapy technology for the treatment of chronic hepatitis B virus (HBV) infection.

January 17, 2018
·
4 min read
Business

Dentsply Sirona Names Cardinal Health Exec as New Leader

Mr. Casey succeeds Mark A. Thierer, who served as Interim Chief Executive Officer since September 28, 2017.

January 17, 2018
·
4 min read
Biotech Beach

Obalon Therapeutics Announces Proposed Public Offering of Common Stock

All of the shares are being offered by Obalon Therapeutics.

January 17, 2018
·
3 min read
Pharm Country

UroGen Pharma Announces Proposed Public Offering of Ordinary Shares

All ordinary shares to be sold in the offering will be offered by the company.

January 17, 2018
·
3 min read
Business

Arcturus Therapeutics Announces Expansion of Collaboration With Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders

Under the deal, Takeda and Arcturus will advance their efforts to develop RNA-based therapeutics for the treatment of NASH and other gastrointestinal related disorders using Arcturus’s wholly-owned LUNAR lipid-mediated delivery systems .and UNA Oligomer chemistry.

January 17, 2018
·
3 min read
Food Safety: Novolyze Raises €2.2 Million to Lower the Risk of Foodborne Illnesses

Of this total, €1.2 million came from private investors, family offices and business angels and the rest from public research programs and grants, including the French government’s Investissement d’Avenir fund.

January 17, 2018
·
3 min read
Business

Medicrea Announces 2018 Financial Calendar

Medicrea announces its financial calendar for the year ending December 31st, 2018.

January 17, 2018
·
1 min read